Hyperinflation and its management in COPD

Luis Puente-Maestu, William W Stringer, Luis Puente-Maestu, William W Stringer

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitation. The pathological hallmarks of COPD are inflammation of the peripheral airways and destruction of lung parenchyma or emphysema. The functional consequences of these abnormalities are expiratory airflow limitation and dynamic hyperinflation, which then increase the elastic load of the respiratory system and decrease the performance of the respiratory muscles. These pathophysiologic features contribute significantly to the development of dyspnea, exercise intolerance and ventilatory failure. Several treatments may palliate flow limitation, including interventions that modify the respiratory pattern (deeper, slower) such as pursed lip breathing, exercise training, oxygen, and some drugs. Other therapies are aimed at its amelioration, such as bronchodilators, lung volume reduction surgery or breathing mixtures of helium and oxygen. Finally some interventions, such as inspiratory pressure support, alleviate the threshold load associated to flow limitation. The degree of flow limitation can be assessed by certain spirometry indexes, such as vital capacity and inspiratory capacity, or by other more complexes indexes such as residual volume/total lung capacity or functional residual capacity/total lung capacity. Two of the best methods to measure flow limitation are to superimpose a flow-volume loop of a tidal breath within a maximum flow-volume curve, or to use negative expiratory pressure technique. Likely this method is more accurate and can be used during spontaneous breathing. A definitive definition of dynamic hyperinflation is lacking in the literature, but serial measurements of inspiratory capacity during exercise will document the trend of end-expiratory lung volume and allow establishing relationships with other measurements such as dyspnea, respiratory pattern, exercise tolerance, and gas exchange.

Figures

Figure 1
Figure 1
Pressure volume relationship of the passive respiratory system. Lower and upper boundaries of the elastic recoil pressure–volume relationship of the respiratory system in healthy subjects (---), in patients with narrowed airways (—), and in patients with loss of lung elastic recoil (·····). The loops represent tidal breathing at rest (—) and during exercise (·····). Abbreviations: FRC, functional residual capacity; VC, vital capacity.
Figure 2
Figure 2
Effects of time and resistance on the change in expiratory volume. Rates of changes of volume after a similar given change of alveolar pressure in a subject with normal respiratory system resistance (—) and a resistance 3 times greater (---) such as in COPD, assuming a constant compliance. Note the marked effect of resistance on the volume change, particularly when the available time is shortened. Abbreviations: COPD, chronic obstructive pulmonary disease.
Figure 3
Figure 3
Iso-volume pressure-flow relationship. Schematic representation of the pressure-flow relationship in a healthy (normal) subject and a patient with COPD, showing the effect of the increased expiratory resistance upon the maximum expiratory flow and in both cases the independence of the maximum flow from the pleural pressure. Copyright © 1986. Modified with permission from Pride NB, Macklem PT. 1986. Lung mechanics in disease. In: Fishman AP (ed). Handbook of physiology, Section 3, Volume III, Part 2: The respiratory system. Bethesda MD: American Physiological Society, pp 659–92. Abbreviations: COPD, chronic obstructive pulmonary disease.
Figure 4
Figure 4
Maximum and tidal flow-volume curves in subjects with and without flow limitation. In this figure it can be seen an schematic representation of the spontaneous flow-volume curves generated at tidal volume at rest (inner dotted line ····) and peak exercise (dashed line ----) compared with the maximum flow volume curve in a subject without flow limitation able to reduce its end-expiratory lung volume (Panel A) and a flow-limited COPD patient with dynamic hyperinflation (Panel B). Abbreviations: COPD, chronic obstructive pulmonary disease; IC, inspiratory capacity.
Figure 5
Figure 5
Tidal volume encroachment by dynamic hyperinflation in COPD. In this figure the effects of respiratory rate and work rate on the end-inspiratory (EILV), end-expiratory lung volume (EELV), tidal volume (ie, EILV–EELV) and minute ventilation in subjects with severe COPD is displayed. While EILV increases with increasing respiratory rate from 20 to 30min−1 (lower left panel), so does EELV resulting in an almost constant (encroached) tidal volume. At respiratory rates higher than 30, though, EILV does not increase any more, however, EELV further increases resulting in a reduced tidal volume and even a drop in ventilation (left upper panel) at respiratory rates higher than 35min−1. In the right lower panel we can see how during progressive exercise tidal volume also decreases at high intensity due again to increase in EELV without parallel increase in EILV (Constructed with data from Puente-Maestu et al 2005). Abbreviation: COPD, chronic obstructive pulmonary disease; EELV, end-expiratory lung volume; EILV, end-inspiratory lung volume; TLC, total lung capacity.

References

    1. [ACCP/AACVPR] Pulmonary Rehabilitation Guidelines Panel, American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation. Pulmonary rehabilitation: joint ACCP/AACVRR evidence based guidelines. Chest. 1997;112:1363–96.
    1. Agostoni E, Hyatt RE. Handbook of physiology The respiratory system, sect 3. 1. III. Bethesda, MD: American Physiological Society; 1986. Static behaviour of the respiratory system; pp. 113–130.
    1. Aldrich TK, Shapiro SM, Sherman MS, et al. Alveolar pressure and airway resistance during maximal and submaximal respiratory efforts. Am Rev Respir Dis. 1989;140:899–906.
    1. Aliverti A, Stevenson N, Dellaca RL, et al. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax. 2004;59:210–16.
    1. Alvisi V, Romanello A, Badet M, et al. Time course of expiratory flow limitation in COPD patients during acute respiratory failure requiring mechanical ventilation. Chest. 2003;123:1625–32.
    1. Armaganidis A, Stavrakaki-Kallergi K, Koutsoukou A, et al. Intrinsic positive end-expiratory pressure in mechanically ventilated patients with and without tidal expiratory flow limitation. Crit Care Med. 2000;28:3837–42.
    1. Babb TG, DeLorey DS, Wyrick BL. Ventilatory response to exercise in aged runners breathing He-O2 or inspired CO2. J Appl Physiol. 2003;94:685–93.
    1. Babb TG, Viggiano R, Hurley B, et al. Effect of mild-to-moderate airflow limitation on exercise capacity. J Appl Physiol. 1991;70:223–30.
    1. Barach AL. Breathing exercises in pulmonary emphysema and alied chronic respiratory disease. Arch Phys Med Reahab. 1955;36:379–90.
    1. Bauerle O, Chrusch CA, Younes M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med. 1998;157:57–68.
    1. Beck KC, Offord KP, Scanlon PD. Bronchoconstriction occurring during exercise in asthmatic patients. Am J Respir Crit Care Med. 1994;149:352–7.
    1. Beeh KM, Beier J, Kornmann O, et al. Long-term repeatability of induced sputum cells and inflammatory kers in stable, moderately severe COPD. Chest. 2003;123:778–83.
    1. Bellee F, Grassino A. Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol. 1982;53:1190–5.
    1. Bellee F, Grassino A Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol. 1983;55:8–15.
    1. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:967–75.
    1. Bianchi L, Foglio K, Pagani M, et al. Effects of proportional assist ventilation on exercise tolerance in COPD patients with chronic hypercapnia. Eur Resp J. 1998;11:422–7.
    1. Bianchi R, Gigliotti F, Romagnoli I, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest. 2004;125:459–65.
    1. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969;99:696–702.
    1. Boni E, Corda L, Franchini D, et al. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax. 2002;57:528–32.
    1. Bowen JB, Votto JJ, Thrall RS, et al. Functional Status and Survival Following Pulmonary Rehabilitation. Chest. 2000;118:697–703.
    1. Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis. 1959;80:194–202.
    1. Brenner M, Hanna NM, Mina-Araghi R, et al. Innovative approaches to lung volume reduction for emphysema. Chest. 2004;126:238–48.
    1. Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J. 2005;25:186–99.
    1. Casaburi R, Gosselink R, Ramer M, et al. American Thoracic Society/European Respiratory Society skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:S1–S40.
    1. Casaburi R, Porszasz J, Burns MR, et al. Am J Respir Crit Care Med. 1997;155:1541–51.
    1. Casaburi R. ACSM resource manual for guidelines for exercise testing and prescription. 4th ed. ACSM; 2001. Special considerations for exercise training; pp. 346–52.
    1. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:591–7.
    1. Celli B, ZuWallack R, Wang S, et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124:1743–8.
    1. Celli BR, Cote CG, Marin JM, et al. The body mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12.
    1. Cherniack RM, Hodson A. Compliance of the Chest wall in chronic bronchitis and emphysema. J Appl Physiol. 1963;18:707–11.
    1. Citterio G, Agostoni E, Del Santo A, et al. Decay of inspiratory muscle activity in chronic airway obstruction. J Appl Physiol. 1981;51:1388–97.
    1. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109:106–16.
    1. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis. 1980;122:265–21.
    1. Coussa ML, Guerin C, Eissa NT, et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol. 1993;75:1711–19.
    1. D’Angelo E, Prandi E, Milic-Emili J. Dependence of maximal flow-volume curves on time-course of preceding inspiration. J Appl Physiol. 1993;75:1155–9.
    1. Dean NC, Brown JK, Himelman RB, et al. Oxygen may improve dyspnoea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis. 1992;146:941–5.
    1. deBoisblanc BP, DeBleiux P, Resweber S, et al. Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease. Crit Care Med. 2000;28:3177–80.
    1. Di Marco J, Milic-Emili J, Boveri P, et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J. 2003;21:86–94.
    1. Diaz O, Villafranca C, Ghezzo H, et al. Exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J. 2000;16:269–75.
    1. Diehl JL, Mercat A, Guerot E, et al. Helium/oxygen mixture reduces the work of breathing at the end of the weaning process in patients with severe chronic obstructive pulmonary disease. Crit Care Med. 2003;31:1415–20.
    1. Diez Herranz A. RV/TLC% ratio: alternative criteria of normality. Eur Respir J. 1995;8:1812–13.
    1. Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction. Am Rev Respir Dis. 1984;129:33–8.
    1. Dolmage TE, Goldstein RS. Proportional assist ventilation and exercise tolerance in subjects with COPD. Chest. 1997;111:948–54.
    1. Dolmage TE, Goldstein RS. Repeatability of inspiratory capacity during incremental exercise in patients with severe COPD. Chest. 2002;121:708–14.
    1. Dolmage TE, Waddell TK, Maltais F, et al. The influence of lung volume reduction surgery on exercise in patients with COPD. Eur Respir J. 2004;23:269–74.
    1. Donahoe M, Rogers RM, Wilson DO, et al. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;140:385–91.
    1. Eltayara L, Becklake MR, Volta CA, et al. Relationship between chronic dyspnoea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:1726–34.
    1. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med. 1998;157:715–22.
    1. Fishman A, Martinez F, Naunheim K, et al. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–73.
    1. Gaissert HA, Trulock EP, Cooper JD, et al. Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1996;111:296–306.
    1. Gallagher CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med. 1994;15:305–26.
    1. Garrod R, Dallimore K, Cook J, et al. An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis. 2005;2:67–72.
    1. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med. 2000;343:239–45.
    1. Gerardi DA, Lovett L, Benoit-Connors ML, et al. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J. 1996;9:431–5.
    1. Gerbeaux P, Gainnier M, Boussuges A, et al. Use of heliox in patients with severe exacerbation of chronic obstructive pulmonary disease. Crit Care Med. 2001;29:2322–4.
    1. Gigliotti F, Coli C, Bianchi R, et al. Exercise training improves exertional dyspnoea in patients with COPD: evidence of the role of mechanical factors. Chest. 2003;123:1794–802.
    1. Gigliotti F, Coli C, Bianchi R, et al. Arm exercise and hyperinflation in patients with COPD: effect of arm training. Chest. 2005;128:1225–32.
    1. Gottlieb DJ, Stone PJ, Sparrow D, et al. Urinary desmosine excretion in smokers with and without rapid line of lung function: the Normative Aging Study. Am J Respir Crit Care Med. 1996;154:1290–5.
    1. Green M, Pride MB. Normal respiratory mechanics. In: Scadding JG, Cumming G, Thrubeck WM, editors. Scientific foundations of respiratory medicine. London: William Heinemann Medical books; 1997. pp. 113–29.
    1. Grimby G, Bunn J, Mead J. Relative contribution of rib cage and abdomen to ventilation during exercise. J Appl Physiol. 1968;24:159–66.
    1. Gross D, Ladd HW, Riley EJ, et al. The effect of training on strength and endurance of the diaphragm in quadriplegia. Am J Med. 1980;68:27–35.
    1. Gunstensen J, McCormack RJ. The surgical management of bullous emphysema. J Thorac Cardiovasc Surg. 1973;65:920–5.
    1. Haas F, Salazar-Schichi J, Axen K. Desensitization to dyspnoea in chronc obstructive pulmonary disease. In: Casaburi R, Petty TL, editors. Principles and practice of pulmonary rehabilitation. Philadelphia: WB Saunders Company; 1993. pp. 241–51.
    1. Hadcroft J, Calverley PM. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax. 2001;56:713–20.
    1. Haluszka J, Chartrand DA, Grassino AE, et al. Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990;141:1194–7.
    1. Hamilton AL, Killian KJ, Summers E, et al. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest. 1996;110:1255–63.
    1. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 1992;5:659–64.
    1. Hazelrigg SR, Boley TM, Naunheim KS, et al. Effect of bovine pericardial strips on air leak after stapled pulmonary resection. Ann Thorac Surg. 1997;63:1573–5.
    1. Henke KG, Sharratt M, Pegelow D, et al. Regulation of end-expiratory lung volume during exercise. J Appl Physiol. 1988;64:135–46.
    1. Hiraga T, Maekura R, Okuda Y, et al. Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing. Clin Physiol Funct Imaging. 2003;23:324–9.
    1. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171:453–60.
    1. Hyatt RE, Wilcox RE. The pressure-flow relationships of the intrathoracic airway in man. J Clin Invest. 1963;42:29–39.
    1. Hyatt RE. The interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjects. Am Rev Respir Dis. 1961;83:676–83.
    1. Hyatt RE. Expiratory flow limitation. J Appl Physiol. 1983;55:1–8.
    1. Im Hof V, West P, Younes M. Steady-state response of normal subjects to inspiratory resistive load. J Appl Physiol. 1986;60:1471–81.
    1. Ingenito EP, Loring SH, Moy ML, et al. Interpreting improvement in expiratory flows after lung volume reduction surgery in terms of flow limitation theory. Am J Respir Crit Care Med. 2001;163:1074–80.
    1. Ingram RH, Jr, Schilder DP. Effect of gas compression on pulmonary pressure, flow, and volume relationship. J Appl Physiol. 1966;21:1821–6.
    1. Ingram RH, Jr, Schilder DP. Effect of pursed lips expiration on the pulmonary pressure-flow relationship in obstructive lung disease. Am Rev Respir Dis. 1967;96:381–8.
    1. Jaber S, Carlucci A, Boussarsar M, et al. Helium-oxygen in the postextubation period decreases inspiratory effort. Am J Respir Crit Care Med. 2001;164:633–7.
    1. Jaber S, Fodil R, Carlucci A, et al. Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1191–200.
    1. Johnson BD, Reddan WG, Seow KC, et al. Mechanical constraints on exercise hyperpnea in a fit aging population. Am Rev Respir Dis. 1991;143:968–77.
    1. Jolliet P, Tassaux D, Thouret JM, et al. Beneficial effects of helium: oxygen versus air: oxygen noninvasive pressure support in patients with descompensated chronic obstructive pulmonary disease. Crit Care Med. 1999;27:2422–9.
    1. Jolly E, Aguirre L, Jorge E, et al. Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease. Medicina (B Aires) 1996;56:472–8.
    1. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530–4.
    1. Keenan RJ, Landreneau RJ, Sciurba FC, et al. Unilateral thoracoscopic surgical approach for diffuse emphysema. J Thorac Cardiovasc Surg. 1996;111:308–15.
    1. Keilty SE, Ponte J, Fleming TA, et al. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax. 1994;49:990–6.
    1. Kervio G, Carre F, Ville NS. Reliability and intensity of the six-minute walk test in healthy elderly subjects. Med Sci Sports Exerc. 2003;35:169–74.
    1. Killian KJ, Jones NL. Mechanisms of exertional dyspnoea. Clin Chest Med. 1994;15:247–57.
    1. Killian KJ, Leblanc P, Tin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992;146:935–40.
    1. Kim MJ, Druz WS, Danon J, et al. Mechanics of the canine diaphragm. J Appl Physiol. 1976;41:369–82.
    1. Knox AJ, Morrison JF, Muers MF. Reproducibility of walking test results in chronic obstructive airways disease. Thorax. 1998;43:388–92.
    1. Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J. 1995;8:306–13.
    1. Kyroussis D, Polkey MI, Hamnegard CH, et al. Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support. Eur Respir J. 2000;15:649–55.
    1. Leith DE, Bradley M. Ventilatory muscle strength and endurance training. J Appl Physiol. 1976;41:508–16.
    1. Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol. 1968;25:21–7.
    1. Liesker JJ, Wijkstra PJ, Ten Hacken NH. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest. 2002;121:597–608.
    1. Light RW, Muro JR, Sato RI, et al. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;139:126–33.
    1. Light RW, Stansbury DW, Webster JS. Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD. Chest. 1996;109:975–81.
    1. Liu AN, Mohammed AZ, Rice WR, et al. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol. 1999;20:849–58.
    1. Lougheed MD, Webb KA, O’Donnell DE. Breathlessness during induced hyperinflation in asthma: role of the inspiratory threshold load. Am J Respir Crit Care Med. 1995;152:911–20.
    1. Mahler DA, Brent BN, Loke J, et al. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984;130:722–9.
    1. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128:1168–78.
    1. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155:555–61.
    1. Maltais F, Reissmann H, Gottfried SB. Pressure support reduces inspiratory effort and dyspnoea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med. 1995;151:1027–33.
    1. Man WD, Mustfa N, Nikoletou D, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax. 2005;59:471–6.
    1. Mannix ET, Manfredi F, Farber MO. Elevated O2 cost of ventilation contributes to tissue wasting in COPD. Chest. 1999;115:708–13.
    1. Marhsall R. Relationships between stimulus and work of breathing at different lung volumes. J Appl Physiol. 1962;17:917–21.
    1. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1395–9.
    1. McGregor M, Becklake MR. The relationship of oxygen cost of breathing to respiratory mechanical work and respiratory force. J Clin Invest. 1961;40:971–80.
    1. Mead J, Turner JM, Macklem PT, et al. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol. 1967;22:95–108.
    1. Milic-Emili J. Provocative hypothesis: does mechanical injury the peripheral airways play a role in the genesis of COPD in smokers? J Chron Obstruc Pulm Dis. 2004;1:1–8.
    1. Miller JD, Berger RL, Malthaner RA, et al. Lung volume reduction surgery vs medical treatment: for patients with advanced emphysema. Chest. 2005;127:1166–77.
    1. Miller JD, Pegelow DF, Jacques AJ, et al. Effects of augmented respiratory muscle pressure production on locomotor limb venous return during calf contraction exercise. J Appl Physiol. 2005;99:1802–15.
    1. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med. 1996;154:1284–9.
    1. Mueller R, Chanez P, Campbell AM, et al. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med. 1996;90:79–85.
    1. Mueller RE, Petty TL, Filley GF. Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol. 1970;28:784–9.
    1. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.
    1. Nathan SD, Edwards LB, Barnett SD, et al. Outcomes of COPD lung transplant recipients after lung volume reduction surgery. Chest. 2004;126:1569–74.
    1. Neder A, Jones PW, Nery LE, et al. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:497–504.
    1. [NETT] National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345:1075–83.
    1. Newton MF, O’Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest. 2002;121:1042–50.
    1. Nickoladze GD. Functional results of surgery for bullous emphysema. Chest. 1992;101:119–22.
    1. Nield M, Arora A, Dracup K, et al. Comparison of breathing patterns during exercise in patients with obstructive and restrictive ventilatory abnormalities. J Rehabil Res Dev. 2003;40:407–14.
    1. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291:755–8.
    1. Nishimura K, Izumi T, Tsukino M, et al. Dyspnoea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.
    1. Nishiyama O, Taniguchi H, Kondoh Y, et al. Factors in maintaining long-term improvements in health-related quality of life after pulmonary rehabilitation for COPD. Qual Life Res. 2005;14:2315–21.
    1. O’Donnell DE, Chau LKL, Bertley JC, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155:109–15.
    1. O’Donnell DE, He Z, Lam M, et al. Reproducibility of measurements of inspiratory capacity, dyspnoea intensity and exercise endurance in multicentre trials in COPD. Eur Respir J. 2004;24:323s.
    1. O’Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med. 2001;164:770–7.
    1. O’Donnell DE, Webb KA. Chapter 18: Exercise. In: Calverley P, MacNee W, Rennard S, et al., editors. Chronic obstructive lung disease. 2nd ed. London: Edward Arnold Ltd; 2003. pp. 243–65.
    1. O’Donnell CE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832–40.
    1. O’Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997;155:530–5.
    1. O’Donnell DE, D’Arsigny C, Fitzpatrick M, et al. Exercise hypercapnia in advanced chronic obstructive pulmonary disease. The role of lung hyperinflation. Am J Respir Crit Care Med. 2002;166:663–8.
    1. O’Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1557–65.
    1. O’Donnell DE, Sanii R, Giesbrecht G, et al. Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am Rev Respir Dis. 1988;138:1185–91.
    1. O’Donnell DE, Sanii R, Younes M. Improvement in exercise endurance in patients with chronic airflow. Limitation using continuous positive airway pressure. Am Rev Respir Dis. 1988;138:1510–14.
    1. O’Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:86–94.
    1. O’Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis. 1993;148:1351–7.
    1. Oga K, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. a comparison of three different exercise tests. Am J Respir Crit Care Med. 2000;161:1897–901.
    1. Oga T, Nishimura K, Tsukino M, et al. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung. 2002;31:374–81.
    1. Oga T, Nishimura K, Tsukino M, et al. Analysis of factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544–49.
    1. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003;100:8407–11.
    1. Oswald-Mammosser M, Apprill M, Bachez P, et al. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration. 1991;58:304–10.
    1. Oswald-Mammosser M, Kessler R, Massard G, et al. Effect of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise. Am J Respir Crit Care Med. 1998;158:1020–5.
    1. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol. 2004;97:1637.
    1. Parker M, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26:420–8.
    1. Pauwels RA, Buist AS, Calverley PMA, et al. Am J Respir Crit Care Med. 2001;163:1256–76.
    1. Pecchiari M, Pelucchi A, D’Angelo E, et al. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest. 2004;125:2075–82.
    1. Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:1605–11.
    1. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.
    1. Pellegrino R, Villosio C, Milanese U, et al. Breathing during exercise in subjects mild-to-moderate airflow obstruction: effects of physical training. J Appl Physiol. 1999:1697–704.
    1. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis. 1982;126:166–70.
    1. Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 1998;12:380–6.
    1. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of airflow obstruction, but not of mucous hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis. 1983;128:491–500.
    1. Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnoea during exercise in severe COPD. J Appl Physiol. 1990;69:179–88.
    1. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28–33.
    1. Polkey MI, Hamnegard CH, Hughes PD. Influence of acute lung volume change on contractile properties of human diaphragm. J Appl Physiol. 1998;85:1322–8.
    1. Polkey MI, Hawkins P, Kyroussis D, et al. Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD. Thorax. 2000;55:547–9.
    1. Poon CS, Younes M, Gallagher CG. Effects of expiratory resistive load on respiratory motor output in conscious humans. J Appl Physiol. 1987;63:1837–45.
    1. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at sub-maximal intensities in patients with COPD. Chest. 2005;128:2025–34.
    1. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest. 1971;50:910–19.
    1. Pride NB, Green M. Abnormalities of respiratory mechanics. In: Scadding JG, Cumming G, Thrubeck WM, editors. Scientific foundations of respiratory medicine. London: William Heinemann Medical Bks; 1997. pp. 669–88.
    1. Pride NB, Macklem PT. Lung mechanics in disease. In: Fishman AP, editor. Handbook of physiology, Section 3, Volume III, Part 2: The respiratory system. Bethesda MD: American Physiological Society; 1986. pp. 659–92.
    1. Pride NB. Tests of forced expiration and inspiration. In: Hughes JMB, Pride NB, editors. Lung function tests: physiological principles and clinical applications. London: WB Saunders; 1999. pp. 3–25.
    1. Puente-Maestu L, García J, Martínez-Abad Y, et al. Dyspnoea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest. 2005;128:651–56.
    1. Puente-Maestu L, Martínez Y, Pedraza F, et al. A controlled trial of the effects of leg training on breathing pattern and dynamic hyperinflation in severe COPD. Lung. 2006;184:159–67.
    1. Puente-Maestu L, SantaCruz A, Vargas T, et al. Effects of training on the tolerance to high-intensity exercise in patients with severe COPD. Respiration. 2003;70:367–70.
    1. Puente-Maestu L, Sánz ML, Sánz P, et al. Comparison of effects of supervised versus self-monitored training programs in patients with chronic obstructive pulmonary disease. Eur Respir J. 2000;15:517–25.
    1. Ramirez-Venegas A, Ward J, Lentine T, et al. Salmeterol reduces dyspnoea and improves lung function in patients with COPD. Chest. 1997;112:336–40.
    1. Ranieri VM, Dambrosio M, Brienza N. Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure. Eur Respir J. 1996;9:1283–92.
    1. Ranieri VM, Giuliani R, Cinnella G, et al. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis. 1993;147:5–13.
    1. Rodrigo G, Rodrigo C, Pollack C, et al. Helium-oxygen mixture for nonintubated acute asthma patients (Cochrane Review) Cochrane Database Syst Rev. 2001;1:CD002884.
    1. Rodrigo GJ, Rodrigo C, Pollack CV, et al. Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest. 2003;123:891–6.
    1. Rogers RM, DuBois AB, Blakemore WS. Effect of removal of bullae on airway conductance and conductance volume ratios. J Clin Invest. 1968;47:2569–79.
    1. Rossi A, Ganassini A, Polese G, et al. Pulmonary hyperinflation and ventilator-dependent patients. Eur Respir J. 1997;10:1663–74.
    1. Roussos C, Macklem PT. The respiratory muscles. N Engl J Med. 1982;307:786–97.
    1. Ruiz de Oña Lacasta JM, Garcia de Pedro J, Puente-Maestu L, et al. Effects of muscle training on breathing pattern in patients with severe chronic obstructive pulmonary disease. Arch Bronconeumol. 2004;40:20–3.
    1. Saetta M, Baraldo S, Corbino L, et al. Am J Respir Crit Care Med. 1999;160:711–17.
    1. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1304–9.
    1. Saksena FB, Burrows B. Thoracic compliance in chronic obstructive lung disease. J Lab Clin Med. 1966;68:427–32.
    1. Salvi S, Blomberg A, Rudell B, et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999;159:702–9.
    1. Schumaker GL, Epstein SK. Managing acute respiratory failure during exacerbation of chronic obstructive pulmonary disease. Respir Care. 2004;49:766–82.
    1. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol. 1999;20:1100–2.
    1. Sharp JT, Van Lith P, Vej Nughprayoon C, et al. The thorax in chronic obstructive lung disease. Am J Med. 1968;44:39–46.
    1. Shindoh C, Hida W, Kikuchi Y, et al. Oxygen consumption of respiratory muscles in patients with COPD. Chest. 1994;105:790–7.
    1. Similowski T, Yan S, Gauthier AP, et al. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med. 1991;325:917–23.
    1. Somfay A, Porszasz J, Lee SM, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001;18:77–84.
    1. Spahija J, de Marchie M, Grassino A. Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnoea at rest and during exercise in COPD. Chest. 2005;128:640–50.
    1. Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax. 2004;59:668–72.
    1. Stevenson NJ, Walker PP, Costello RW, et al. Lung mechanics and dyspnoea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:1510–16.
    1. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med. 1999;160:S49–S52.
    1. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of the European Respiratory Society. Eur Respir J. 1995;8:492–506.
    1. Stubbing DG, Pengelly LD, Morse JL, et al. Pulmonary mechanics during exercise in normal males. J Appl Physiol. 1980;49:506–10.
    1. Suratt BT, Cool CD, Serls AE, et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003;168:318–22.
    1. Swidwa DM, Montenegro HD, Goldman MD, et al. Helium-oxygen breathing in severe chronic obstructive pulmonary disease. Chest. 1985;87:790–5.
    1. Takayama T, Shindoh C, Kurokawa Y, et al. Effects of lung volume reduction surgery for emphysema on oxygen cost of breathing. Chest. 2003;123:1847–52.
    1. Tassaux D, Jolliet P, Roeseler J, et al. Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanically ventilated patients with severe chronic obstructive pulmonary disease. Crit Care Med. 2000;28:2721–8.
    1. Thoman RL, Stoker GL, Ross JC. The efficacy of pursed-lips breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1966;93:100–6.
    1. Thurlbeck W. Pathology of chronic airflow obstruction. In: Cherniack N, editor. Chronic obstructive pulmonary disease. Philadelphia: WB Saunders; 1991. pp. 3–20.
    1. Thurlbeck WM. Chronic airflow obstruction. Correlation of structure and function. In: Petty TL, editor. Chronic obstructive pulmonary disease. New York: Marcel Dekker; 1985. pp. 129–204.
    1. Tiep BL, Burns M, Kao D, et al. Pursed lips breathing training using ear oximetry. Chest. 1986;90:218–21.
    1. Tobin MJ, Hughes JA, Hutchison DC. Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance. Eur J Respir Dis. 1984;65:441–6.
    1. Tojo N, Ichioka M, Chida M, et al. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med. 2005;44:20–5.
    1. Valta P, Corbeil C, Lavoie A, et al. Detection of expiratory flow limitation during mechanical ventilation. Am J Respir Crit Care Med. 1994;150:1311–17.
    1. van’t Hul AJ, Kwakkel G, Gosselink R. The acute effects of non-invasive ventilatory support during exercise on exercise endurance and dyspnoea in patients with COPD: a systematic review. J Cardiopulm Rehabil. 2002;22:290–7.
    1. van’t Hul A, Gosselink R, Hollander P, et al. Acute effects of inspiratory pressure support during exercise in patients with COPD. Eur Respir J. 2004;23:34–40.
    1. Vestbo J, Prescott E, Lange Pl the Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 line and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med. 1996;153:1530–5.
    1. Vogiatzis I, Georgiadou O, Golemati S, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax. 2005;60:723–9.
    1. Vogiatzis I, Nanas S, Kastanakis E, et al. Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD. Eur Respir J. 2004;24:385–90.
    1. Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002;20:12–19.
    1. Von Essen SG, O’Neill DP, McGranaghan S, et al. Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest. 1995;108:1425–33.
    1. Wakabayashi A, Brenner M, Kayaleh RA, et al. Thoracoscopic carbon dioxide laser treatment of bullous emphysema. Lancet. 1991;337:881–3.
    1. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in “pink puffers”. Lancet. 1981;i:907–9.
    1. Woodcock AA, Gross ER, Gellert A, et al. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981;305:1611–16.
    1. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest. 1997;112:505–10.
    1. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 1997;156:55–9.
    1. Younes M, Kivinen G. Respiratory mechanics and breathing pattern during and following maximal exercise. J Appl Physiol. 1984;57:1773–82.
    1. Younes M, Riddle W. A model for the relation between respiratory neural and mechanical outputs. I. Theory. J Appl Physiol. 1981;51:963–78.
    1. Younes M. Determinants of thoracic excursion during exercise. In: Whipp BJ, Wasserman K, editors. Exercise pulmonary physiology and physiopathology. New York: Marcel Dekker; 1991. pp. 1–65.

Source: PubMed

3
購読する